Literature DB >> 28893575

Clinical Characteristics and Outcomes of Intracerebral Hemorrhage in Very Elderly.

Yasuteru Inoue1, Fumio Miyashita2, Kazuo Minematsu2, Kazunori Toyoda2.   

Abstract

BACKGROUND: Intracerebral hemorrhage (ICH) incidences increase with age. Patients of advanced age may have limitations during acute care and recovery. We investigated baseline characteristics, hematoma features, and outcomes of very elderly ICH patients (≥80 years old) and compared them with those of younger ICH patients (<80 years old).
METHODS: We studied 377 patients (122 women; 69 ± 11 years old) admitted within 24 hours of ICH onset. Outcome measures included hematoma volumes, National Institutes of Health Stroke Scale scores on admission, and vital and functional prognoses at 30 days.
RESULTS: After adjustments for sex, very elderly patients had a higher subcortical hematoma prevalence (odds ratio [OR], 2.62; 95% confidence interval [CI], 1.39-4.86]. On multivariate analyses, very elderly patients had larger hematoma volumes (OR, 1.33; 95% CI, 1.01-1.75, per 10-mL increase). After adjustments for risk factors and comorbidities, modified Rankin scale scores of 0-2 in very elderly patients occurred less often (OR, .34; 95% CI, .14-.82), and those with scores of 5-6 occurred more often (OR, 3.01; 95% CI, 1.09-8.54).
CONCLUSIONS: Hematomas were relatively large and often found in the subcortex in very elderly ICH patients. Outcomes of very elderly ICH patients were relatively poor.
Copyright © 2018 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intracerebral hemorrhage; cerebral amyloid angiopathy; elderly; outcomes

Mesh:

Year:  2017        PMID: 28893575     DOI: 10.1016/j.jstrokecerebrovasdis.2017.08.006

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  8 in total

Review 1.  Prevention and Treatment of Acute Stroke in the Nonagenarians and Beyond: Medical and Ethical Issues.

Authors:  Tiberiu A Pana; Jesus A Perdomo-Lampignano; Phyo K Myint
Journal:  Curr Treat Options Neurol       Date:  2019-05-08       Impact factor: 3.598

Review 2.  Intracerebral Hemorrhage: The Effects of Aging on Brain Injury.

Authors:  Noah Watson; Frederick Bonsack; Sangeetha Sukumari-Ramesh
Journal:  Front Aging Neurosci       Date:  2022-04-25       Impact factor: 5.702

3.  [Acute stroke treatment in old age].

Authors:  Frank Erbguth
Journal:  Z Gerontol Geriatr       Date:  2019-11-29       Impact factor: 1.281

Review 4.  Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy.

Authors:  Yasuteru Inoue; Yukio Ando; Yohei Misumi; Mitsuharu Ueda
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

5.  Simultaneous presentation of subcortical hemorrhage, subdural hemorrhage, and cerebral infarct in a hemiplegic patient.

Authors:  Hiroki Sugiyama; Satoshi Tsutsumi; Aito Watanabe; Senshu Nonaka; Hidehiro Okura; Hisato Ishii
Journal:  Radiol Case Rep       Date:  2022-03-02

6.  Machine learning model prediction of 6-month functional outcome in elderly patients with intracerebral hemorrhage.

Authors:  Gianluca Trevisi; Valerio Maria Caccavella; Alba Scerrati; Francesco Signorelli; Giuseppe Giovanni Salamone; Klizia Orsini; Christian Fasciani; Sonia D'Arrigo; Anna Maria Auricchio; Ginevra D'Onofrio; Francesco Salomi; Alessio Albanese; Pasquale De Bonis; Annunziato Mangiola; Carmelo Lucio Sturiale
Journal:  Neurosurg Rev       Date:  2022-05-06       Impact factor: 2.800

7.  Cerebral Microangiopathy Mimicking a High-Grade Glioma in Old Age: A Case Report.

Authors:  Young Min Kwon; Song-Hee Han; Kyoung Su Sung; Young Jin Song
Journal:  Brain Tumor Res Treat       Date:  2022-07

8.  Development and validation of a nomogram to predict the 30-day mortality risk of patients with intracerebral hemorrhage.

Authors:  Jianyu Zou; Huihuang Chen; Cuiqing Liu; Zhenbin Cai; Jie Yang; Yunlong Zhang; Shaojin Li; Hongsheng Lin; Minghui Tan
Journal:  Front Neurosci       Date:  2022-08-10       Impact factor: 5.152

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.